|
1
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Azeem K, Kollarova H, Horakova D,
Magnuskova S and Janout V: Genetic syndromes associated with renal
cell carcinoma: A review. Biomed Pap Med Fac Univ Palacky Olomouc
Czech Repub. 155:231–238. 2011. View Article : Google Scholar
|
|
3
|
Novick AC: Kidney cancer: Past, present
and future. Urol Oncol. 25:188–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
7
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prud'homme GJ: Cancer stem cells and novel
targets for antitumor strategies. Curr Pharm Des. 18:2838–2849.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z,
Fan Y, Chen X and Wu C: Re-expression of miR-21 contributes to
migration and invasion by inducing epithelial-mesenchymal
transition consistent with cancer stem cell characteristics in
MCF-7 cells. Mol Med Biochem. 363:427–436. 2012.
|
|
11
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM:
Overexpression of snail induces epithelial-mesenchymal transition
and a cancer stem cell-like phenotype in human colorectal cancer
cells. Cancer Med. 1:5–16. 2012. View
Article : Google Scholar
|
|
12
|
Kanzawa M, Semba S, Hara S, Itoh T and
Yokozaki H: WNT5A is a key regulator of the epithelial-mesenchymal
transition and cancer stem cell properties in human gastric
carcinoma cells. Pathobiology : journal of immunopathology,
molecular and cellular biology. 80:235–244. 2013. View Article : Google Scholar
|
|
13
|
Luo Y, Cui XH, Jiang YG, et al:
Epithelial-mesenchymal transition of prostate cancer: cancer stem
cells or bulk cancer cells. Zhonghua yi xue za zhi. 93:256–260.
2013.PubMed/NCBI
|
|
14
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: Migrating cancer stem cells-an integrated
concept of malignant tumour progression. Nat Rev Cancer. 5:744–749.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamura T, Scorilas A, Stephan C, Yousef
GM, Kristiansen G, Jung K and Diamandis EP: Quantitative analysis
of macrophage inhibitory cytokine-1 (MIC-1) gene expression in
human prostatic tissues. Br J Cancer. 88:1101–1104. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheung J, Mak YT, Papaioannou S, Evans BA,
Fogelman I and Hampson G: Interleukin-6 (IL-6), IL-1, receptor
activator of nuclear factor kappaB ligand (RANKL) and
osteoprotegerin production by human osteoblastic cells: comparison
of the effects of 17-beta oestradiol and raloxifene. J Endocrinol.
177:423–433. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Bera A, Das F, Ghosh-Choudhury N, Kasinath
BS, Abboud HE and Choudhury GG: MicroRNA-21-induced dissociation of
PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate
renal cancer cell invasion. Exp Cell Res. 328:99–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sheth S, Jajoo S, Kaur T, Mukherjea D,
Sheehan K, Rybak LP and Ramkumar V: Resveratrol reduces prostate
cancer growth and metastasis by inhibiting the Akt/MicroRNA-21
pathway. PLoS One. 7:e516552012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bornachea O, Santos M, Martinez-Cruz AB,
García-Escudero R, Dueñas M, Costa C, Segrelles C, Lorz C, Buitrago
A, Saiz-Ladera C, et al: EMT and induction of miR-21 mediate
metastasis development in Trp53-deficient tumours. Sci Rep.
2:4342012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang B, Huang YJ, Yao ZJ, Chen X, Guo SJ,
Mao XP, Wang DH, Chen JX and Qiu SP: Cancer stem cell-like side
population cells in clear cell renal cell carcinoma cell line 769P.
PLoS One. 8:e682932013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lichner Z, Saleh C, Subramaniam V,
Seivwright A, Prud'homme GJ and Yousef GM: MiR-17 inhibition
enhances the formation of kidney cancer spheres with stem
cell/tumor initiating cell properties. Oncotarget. 6:5567–5581.
2015. View Article : Google Scholar :
|
|
24
|
Li L, Zhou L, Li Y, Lin S and Tomuleasa C:
MicroRNA-21 stimulates gastric cancer growth and invasion by
inhibiting the tumor suppressor effects of programmed cell death
protein 4 and phosphatase and tensin homolog. J Buon. 19:228–236.
2014.PubMed/NCBI
|
|
25
|
Selcuklu SD, Donoghue MT and Spillane C:
MiR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Prco Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar
|
|
27
|
Brase JC, Johannes M, Schlomm T, Fälth M,
Haese A, Steuber T, Beissbarth T, Kuner R and Sültmann H:
Circulating miRNAs are correlated with tumor progression in
prostate cancer. Int J Cancer. 128:608–616. 2011. View Article : Google Scholar
|
|
28
|
Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang
SL, Dai B, Zhu YP, Shen YJ, Shi GH and Ye DW: Serum miRNA-21:
Elevated levels in patients with metastatic hormone-refractory
prostate cancer and potential predictive factor for the efficacy of
docetaxel-based chemotherapy. Prostate. 71:326–331. 2011.
View Article : Google Scholar
|
|
29
|
Moltzahn F, Olshen AB, Baehner L, Peek A,
Fong L, Stöppler H, Simko J, Hilton JF, Carroll P and Blelloch R:
Microfluidic-based multiplex qRT-PCR identifies diagnostic and
prognostic microRNA signatures in the sera of prostate cancer
patients. Cancer Res. 71:550–560. 2011. View Article : Google Scholar :
|
|
30
|
Saini S, Majid S, Yamamura S, Tabatabai L,
Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y and Dahiya R:
Regulatory role of mir-203 in prostate cancer progression and
metastasis. Clin Cancer Res. 17:5287–5298. 2011. View Article : Google Scholar
|
|
31
|
Collyer TC, Yates DR and Bellamy MC:
Severe air embolism resulting from a perforated cap on a high-flow
three-way stopcock connected to a central venous catheter. Eur J
Anaesthesiol. 24:474–475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Catto JW, Abbod MF, Wild PJ, Linkens DA,
Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R,
et al: The application of artificial intelligence to microarray
data: Identification of a novel gene signature to identify bladder
cancer progression. Eur Urol. 57:398–406. 2010. View Article : Google Scholar
|
|
33
|
Neely LA, Rieger-Christ KM, Neto BS,
Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino
JA, Whitney D and Summerhayes IC: A microRNA expression ratio
defining the invasive phenotype in bladder tumors. Urol Oncol.
28:39–48. 2010. View Article : Google Scholar
|
|
34
|
Liu H, Brannon AR, Reddy AR, Alexe G,
Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, et al:
Identifying mRNA targets of microRNA dysregulated in cancer: With
application to clear cell renal cell carcinoma. BMC Syst Biol.
4:512010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu W, Zabirnyk O, Wang H, Shiao YH,
Nickerson ML, Khalil S, Anderson LM, Perantoni AO and Phang JM:
miR-23b targets proline oxidase, a novel tumor suppressor protein
in renal cancer. Oncogene. 29:4914–4924. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Catto JW, Alcaraz A, Bjartell AS, De Vere
White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L,
Schlomm T and Visakorpi T: MicroRNA in prostate, bladder and kidney
cancer: A systematic review. Eur Urol. 59:671–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baker M: Cancer stem cells tracked.
Nature. 488:13–14. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blagosklonny MV: Target for cancer
therapy: Proliferating cells or stem cells. Leukemia. 20:385–391.
2006. View Article : Google Scholar
|
